Citadel Advisors’s Crinetics Pharmaceuticals CRNX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$654K	Sell	18,000 -1,700	-9%	-$75.9K	﹤0.01%	8647
2025 Q4	$917K	Sell	19,700 -89,100	-82%	-$3.97M	﹤0.01%	7587
2025 Q3	$4.53M	Buy	108,800 +69,100	+174%	+$2.21M	﹤0.01%	4537
2025 Q2	$1.14M	Buy	39,700 +21,300	+116%	+$658K	﹤0.01%	6789
2025 Q1	$617K	Buy	18,400 +7,400	+67%	+$276K	﹤0.01%	8013
2024 Q4	$562K	Buy	11,000 +3,700	+51%	+$207K	﹤0.01%	8301
2024 Q3	$373K	Buy	7,300 +2,200	+43%	+$113K	﹤0.01%	8861
2024 Q2	$228K	Sell	5,100 -54,900	-92%	-$2.54M	﹤0.01%	9654
2024 Q1	$2.81M	Buy	60,000 +34,500	+135%	+$1.35M	﹤0.01%	4895
2023 Q4	$907K	Sell	25,500 -8,400	-25%	-$258K	﹤0.01%	6869
2023 Q3	$1.01M	Buy	33,900 +32,800	+2,982%	+$676K	﹤0.01%	6537
2023 Q2	$19.8K	Sell	1,100 -21,500	-95%	-$429K	﹤0.01%	12733
2023 Q1	$363K	Buy	22,600 +20,300	+883%	+$376K	﹤0.01%	8981
2022 Q4	$42.1K	Sell	2,300 -121,200	-98%	-$2.14M	﹤0.01%	12351
2022 Q3	$2.43M	Sell	123,500 -10,100	-8%	-$206K	﹤0.01%	5220
2022 Q2	$2.49M	Buy	+133,600	New	+$2.67M	﹤0.01%	5112